Latest news

Accessibility

  1. Contrast:

Cancer Drugs Fund consultation

NHS England and NICE have launched a 12-week public consultation seeking views about proposals for the future direction of the Cancer Drugs Fund (CDF).

During the consultation period, which runs until 11 February 2016, NHS England and NICE will be hosting a number of face-to-face events, and webinars, to enable you to hear more about the proposals, and to ask questions. The aim of these events is to provide you with an opportunity to learn more, and clarify any points, so that you can contribute your views to the online consultation in an informed way.

Please see below for details of the face-to-face events, scheduled for January 2016, as well as webinars running before Christmas. Further webinar dates will be posted in the New Year.

Webinars

There will be two webinars before Christmas:

  • Thursday 17 December – 11am
  • Thursday 17 December – 1pm

Each of the webinars will last for approximately 1.5 hours and are both open to anybody with an interest in the future direction of the CDF. Additional webinars will be organised in the New Year, some of which will be targeted at specific audiences e.g. patient groups and charities.

Each webinar is limited to 40 places. Once capacity for a webinar has been reached, you will not be able to join. In this case, please register for another event, or look out for details of further events in the New Year. We will sending out another email like this one as soon as we have the additional dates.

 

Face to face events

There will be two face-to-face events in January. Anybody with an interest in the future of the Cancer Drugs Fund is welcome to attend. Please note that places are limited, so please do register early if you wish to attend. The dates are:

  • Wednesday 13 January – London – 10am – 12.30pm
  • Friday 15 January – Manchester – 2pm – 4.30pm

 

We have placed cookies on your computer to help make this website better. You can at any time read our cookie policy. Otherwise, we will assume that you’re OK to continue.

Change cookie settings: